Kymera Therapeutics (KYMR) Financials

The income statement of Kymera Therapeutics, Inc. (KYMR) provides an overview of the financial performance of the company. It shows the revenue, expenses, and ultimately the net income generated during a specific period. The gross profit represents the difference between the revenue and the cost of goods sold. This measure helps evaluate the profitability of the company's core operations. Net income from stockholders reflects the portion of the net income attributable to stockholders after accounting for any preferred stock dividends. The total revenue represents the sum of all sources of revenue for the company, including sales of products, licensing fees, and any other income.

The balance sheet of Kymera Therapeutics, Inc. (KYMR) provides a snapshot of the company's financial position at a specific point in time. It lists the company's assets, liabilities, and stockholders' equity. Total assets represent the sum of all the company's resources, including cash, accounts receivable, inventory, property, and equipment. Total liabilities include all the company's obligations, such as accounts payable, loans, and other liabilities. Stockholders' equity represents the net worth of the company, which is the residual interest after deducting liabilities from assets. Cash equivalents refer to highly liquid investments that are readily convertible into cash without a significant risk of value loss. Net debt represents the company's total debt minus its cash and cash equivalents.

The cash flow statement of Kymera Therapeutics, Inc. (KYMR) reveals the sources and uses of cash during a specific period. It consists of three sections: operating activities, investing activities, and financing activities. Operating cash flow provides information about the cash generated or used in the company's core operations. Investing cash flow shows the cash flows from investments in long-term assets, such as property, plant, and equipment. Financing cash flow includes cash flows related to raising or repaying capital, such as issuing or repurchasing stock, and borrowing or repaying loans. Free cash flow represents the cash remaining after deducting capital expenditures from operating cash flow. It indicates the company's ability to generate cash that can be used for expansion, debt repayment, or distribution to shareholders.